This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Spectrum Pharmaceuticals Inc (SPPI)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 156.31M 139.70M 121.20M 53.56M
Receivables 57.02M 92.17M 51.70M 21.05M
Inventories 13.52M 14.48M 10.76M 4.23M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 235.19M 264.87M 225.80M 121.86M
Property, Plant & Equipment, Gross 10.60M 9.86M 6.38M 5.97M
Accumulated Depreciation & Depletion 9.07M 7.32M 3.70M 2.81M
Property, Plant & Equipment, Net 1.54M 2.55M 2.68M 3.16M
Intangibles 231.35M 202.31M 41.65M 29.60M
Other Non-Current Assets 12.58M 7.57M 10.64M 9.00M
Total Non-Current Assets 263.96M 241.40M 54.98M 41.77M
Liabilities & Shareholder Equity
Total Assets 499.16M 506.27M 280.78M 163.63M
Accounts Payable 12.80M 34.35M 9.80M 38.70M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 3.12M 35.61M 15.85M 3.90M
Total Current Liabilities 89.98M 128.40M 78.54M 63.32M
Long Term Debt 91.48M 75.00M 0.00 0.00
Deferred Income Taxes 7.17M 14.31M 0.00 0.00
Other Non-Current Liabilities 28.92M 3.72M 14.03M 25.79M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 127.56M 93.03M 14.34M 25.83M
Total Liabilities 217.55M 221.43M 92.87M 89.16M
Preferred Stock Equity 123.00K 123.00K 123.00K 160.00K
Common Stock Equity 281.48M 284.72M 187.78M 74.32M
Common Par 64.00K 60.00K 59.00K 51.00K
Additional Paid In Capital 518.14M 463.71M 452.76M 384.76M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -237.62M -179.32M -261.88M -310.40M
Treasury Stock 0.00 0.00 -2.93M 0.00
Other Equity Adjustments 894.00K 273.00K -227.00K -92.00K
Total Capitalization 373.09M 359.85M 187.91M 74.48M
Total Equity 281.61M 284.85M 187.91M 74.48M
Total Liabilities & Stock Equity 499.16M 506.27M 280.78M 163.63M
Total Common Shares Outstanding 64.10M 60.03M 59.25M 51.46M
Preferred Shares 20.00 20.00 20.00 26.00
Treasury Shares 0.00 0.00 363.06K 0.00
Basic Weighted Shares Outstanding 60.73M 58.59M 53.27M 49.50M
Diluted Weighted Shares Outstanding 60.73M 64.64M 57.96M 49.50M
Number of Employees 226 193 176 139
Number of Part-Time Employees 0 0 0 0
SPPI News

SPPI Spectrum Pharmaceuticals Inc

Analysts Ratings for SPPI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 1 1
Moderate Buy 0 0 0 0
Hold 1 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SPPI ANALYST REPORT

Brokerage Partners

SPPI Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs